Bon Natural Life Ltd. Files September 2025 6-K Report
Ticker: BON · Form: 6-K · Filed: Sep 29, 2025 · CIK: 1816815
Sentiment: neutral
Topics: reporting, compliance, foreign-private-issuer
TL;DR
Bon Natural Life (BNL) filed its monthly 6-K, confirming 20-F annual report filings and its China-based operations.
AI Summary
Bon Natural Life Ltd. filed a Form 6-K on September 29, 2025, for the month of September 2025. The company, based in Xi'an, China, is a foreign private issuer and will file its annual reports under Form 20-F. The filing provides information regarding its principal executive offices and mailing address.
Why It Matters
This filing indicates ongoing reporting compliance for Bon Natural Life Ltd., a company operating in the medicinal chemicals and botanical products sector.
Risk Assessment
Risk Level: low — This is a routine monthly filing (6-K) that does not contain significant new financial or operational information.
Key Players & Entities
- Bon Natural Life Ltd (company) — Registrant
- 0001493152-25-015913 (filing_id) — Accession Number
- 20250929 (date) — Filing Date
- Xi'an (location) — Principal Executive Offices
FAQ
What type of annual report does Bon Natural Life Ltd. file?
Bon Natural Life Ltd. files its annual reports under cover of Form 20-F.
What is the filing date of this Form 6-K?
This Form 6-K was filed on September 29, 2025.
Where are Bon Natural Life Ltd.'s principal executive offices located?
Bon Natural Life Ltd.'s principal executive offices are located in Xi'an, People's Republic of China.
What is the SIC code for Bon Natural Life Ltd.?
The Standard Industrial Classification (SIC) code for Bon Natural Life Ltd. is 2833, which corresponds to Medicinal Chemicals & Botanical Products.
Is Bon Natural Life Ltd. submitting this Form 6-K in paper format?
The filing indicates that the company is not submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1).
Filing Stats: 4,231 words · 17 min read · ~14 pages · Grade level 10.2 · Accepted 2025-09-29 09:27:41
Key Financial Figures
- $7,949,845 — hlights Revenue - Total revenues were $7,949,845 for the six months ended March 31, 2025
- $2,233,708 — ths ended March 31, 2025, a decrease of $2,233,708, or 21.9% as compared to $10,183,553 in
- $10,183,553 — of $2,233,708, or 21.9% as compared to $10,183,553 in the same period of 2024. Income fr
- $284,050 — the six months ended March 31, 2025 was $284,050, an increase of $199,545 or 236.1% as c
- $199,545 — h 31, 2025 was $284,050, an increase of $199,545 or 236.1% as compared to $84,505 in the
- $84,505 — se of $199,545 or 236.1% as compared to $84,505 in the same period of 2024. Net incom
- $169,227 — the six months ended March 31, 2025 was $169,227 as compared to a net loss attributable
- $10,519 — ibutable to BON Natural Life Limited of $10,519 in the same period of 2024. Income (L
- $0.56 — r Class A and Class B ordinary share of $0.56 and a diluted earnings per Class A and
- $0.50 — rnings per Class A and Class B share of $0.50 for the six months ended March 31, 2025
- $0.20 — , 2025 as compared to Loss per share of $0.20 for the six months ended March 31, 2024
- $4,797,718 — ompound products increased by 553.9% or $4,797,718 to $5,663,910 in the six months ended M
- $5,663,910 — ts increased by 553.9% or $4,797,718 to $5,663,910 in the six months ended March 31, 2025
- $866,192 — he six months ended March 31, 2025 from $866,192 in the same period of 2024. The increas
- $2,076,080 — drinks) products decreased by 97.6% or $2,076,080 to $50,067 in the six months ended Marc
Filing Documents
- form6-k.htm (6-K) — 161KB
- ex99-1.htm (EX-99.1) — 134KB
- 0001493152-25-015913.txt ( ) — 296KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: September 29, 2025 Bon Natural Life Limited By: /s/ Yongwei Hu Yongwei Hu Chairman and Chief Executive Officer EXHIBIT INDEX Exhibit No. Description 99.1 Unaudited Condensed Consolidated Financial Statements for the Six Months Ended March 31, 2025